Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Medical and surgical device makers are riding on a surge in demand as more people in the U.S., particularly older Americans, ...

Danielle Antalffy; Analyst; UBS Equities Michael Polark; Analyst; Wolfe Research ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, expectations were $3.87. Operator: Welcome to the Fourth Quarter 2024 Stryker ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

Stryker Corporation SYK recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi ...

In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Stryker (SYK – Research Report), with a price target of ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings ...

Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.